Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Global TB Drug Facility

This fact sheet explains the purpose of the Global Drug Facility (GDF) to expand access to, and availability of, high-quality TB drugs to facilitate DOTS expansion, and to enable governments and nongovernmental organizations (NGOs) to implement effective TB control programs based upon the DOTS stragegy.

Author:

Stop TB Partnership

Audiences:

International Agencies

Topic:

Program Management, Treatment- Directly Observed Therapy (DOT)

Related Materials

Prospectus: Global TB Drug Facility: A Global Mechanism to Ensure Uninterrupted Access to Quality TB Drugs for DOTS Implementation

This prospectus is a culmination of input from Stop TB Partners including representatives from TB high-burden countries, UN agencies, Nongovernmental Organizations (NGOs), and foundations to develop the form, strategies, objectives, and governance of the Global TB Drug Facility (GDF).

Report

Prospectus: Global TB Drug Facility: A Global Mechanism to Ensure Uninterrupted Access to Quality TB Drugs for DOTS Implementation

This report presents information about the Global TB Drug Facility, a program designed to ensure access to and the availability of TB drugs.

Report

4 Million Treatments in 4 Years: The Global TB Drug Facility Achievements Report

This is an achievement report about the Global Drug Facility (GDF), a key initiative of the STOP TB Partnership, which has had a positive impact on the treatment of millions of TB patients globally since its establishment in 2001. By providing high-quality TB drugs to over 4.4 million people in some of the world's poorest countries, it has helped to save lives and has significantly strengthened global TB control efforts.

Report

Global resources for the prevention,
management, and elimination of TB.